Billionaire money managers reduced their holdings in these popular stocks last quarter, but was it a smart move?
Investors shouldn't pay much attention to recent supply-chain rumors purporting to predict iPhone 7 demand.
This platform has been dying for years. Apple delivered the lethal poison, and now Google is simply cremating what remains.
The biotech's numbers are meaningless, but an update on one of its programs sent the stock down.
Google adds new features to Android, but has it become a follower instead of an innovator?
Our healthcare contributors think these five stocks might be on big pharma's shopping list.
It was a good week for healthcare ETFs, but this one fund put up a stellar performance.
Apple shifted some of its budget from AWS to Google's cloud.
Comments from this Apple supplier suggest an improved version of 3D Touch is coming to iPhone this fall.
This stock most certainly isn't every investor's cup of tea. Does it belong in your portfolio? Let's find out!